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According to in vitro assays, T cells are thought to kill
rapidly and efficiently, but the efficacy and dynamics
of cytotoxic T lymphocyte (CTL)-mediated killing
of virus-infected cells in vivo remains elusive. We
used two-photon microscopy to quantify CTL-medi-
ated killing in mice infected with herpesviruses or
poxviruses. On average, one CTL killed 2–16 virus-
infected cells per day as determined by real-time
imaging and by mathematical modeling. In contrast,
upon virus-induced MHC class I downmodulation,
CTLs failed to destroy their targets. During killing,
CTLs remained migratory and formed motile kinap-
ses rather than static synapses with targets. Viruses
encoding the calcium sensor GCaMP6s revealed
strong heterogeneity in individual CTL functional
capacity. Furthermore, the probability of death of in-
fected cells increased for those contacted by more
than two CTLs, indicative of CTL cooperation.
Thus, direct visualization of CTLs during killing of
virus-infected cells reveals crucial parameters of
CD8+ T cell immunity.
INTRODUCTION
CD8+ cytotoxic T lymphocytes (CTLs) play an essential role in
combating viral infections (Zhang and Bevan, 2011). Duringactivation by antigen-presenting cells, CTLs integrate T cell
receptor (TCR), co-stimulatory, and cytokine receptor signaling
to fine-tune proliferation and differentiation and establish various
effector cell subtypes characterized by the expression of
different surface markers and cytokine production abilities
(Marchingo et al., 2014). Together, these mechanisms allow
the generation of CTL responses that can defend the host organ-
ism during primary infection and provide protective immunity
against reinfection.
Primed CTLs are able to detect viral peptides restricted to
major histocompatibility complex class I (MHC-I) and establish
a TCR-triggered immunological synapse with their targets
to secrete the content of their cytotoxic granules toward the
infected cell (Dustin, 2008). The targeted secretion of several
effector proteins, such as granzymes and perforin, triggers the
cell-death machinery in the infected cell while leaving antigen-
negative bystander cells intact (Lopez et al., 2012). Furthermore,
CTLs secrete various cytokines that contribute to antiviral im-
munity. However, it remains unclear how important the con-
tact-dependent killing of target cells is in relation to these indirect
mechanisms of control.
The efficiency of CTL-mediated contact-dependent killing
of different cell types has been studied extensively in vitro.
Such studies have suggested that CTLs can rapidly, serially,
and even simultaneously kill multiple target cells within minutes
(Wiedemann et al., 2006). However, assays of in vitro killing
have a limited capacity to reflect the situation of how CTLs
sense, reach, and interact with infected cells in a three-dimen-
sional tissue in vivo. Whereas many assays of in vitro killing
involve CTLs and targets co-cultured in suspension or as cell
pellets, access to infected cells is likely to be limited in the intactImmunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc. 233
tissue in which only selected cells are infected with viruses. Also,
the extracellular matrix and bystander cells might exert multiple,
often suppressive effects on CTL function (Zhang and Bevan,
2011). In addition, in co-culture killing assays, CTLs are brought
passively together with target cells, whereas in vivo killing re-
quires active CTL sensing and migration (Germain et al., 2012).
Thus, it remains unclear how fast and how robustly virus-infected
cells are killed by single CTLs in different virus-infected tissues
(Elemans et al., 2014; Elemans et al., 2012; Hickman et al.,
2015; Hogan et al., 2014).
In the current study, we quantified CTL killing kinetics by
two-photon microscopy in mice infected with murine cytomega-
lovirus (MCMV) or modified vaccinia virus Ankara (MVA). To this
end, we used ex vivo two-photon imaging of explanted lymph
nodes and in vivo imaging of intact skin together with transgenic
and natural CTLs and virus-expressed functional reporter sys-
tems. Importantly, we found that not every contact between
CTLs and target cells led to a perforin-dependent Ca2+ flux
and target-cell death. Using datasets on single-cell tracking,
we estimated the average per capita killing rates (PCKRs: the
number of targets killed per CTL per day) of transgenic and
endogenous CTLs that kill different types of cells infected with
several strains and species of viruses. In contrast to the con-
ventional theory of ‘‘highly efficient’’ killing, our results consis-
tently showed that PCKRs in vivo were overall limited to a
value of about 2–16 infected cells killed per CTL per day. Further-
more, we observed that viral MHC-I immune evasion strongly
reduced CTL-mediated antigen-specific contact-dependent
killing in vivo. Finally, we showed that by increasing the proba-
bility of target-cell death after multiple encounters, CTLs could
cooperate during killing of virus-infected cells.
RESULTS
Single-Cell Visualization Allows for Quantification of
Virus-Infected Cells
To determine killing kinetics of CTLs in vivo, we infected mice
with MCMV reporter strains (Marquardt et al., 2011). MCMV-
2D expresses the red fluorescent protein (FP) mCherry and
a secretable Gaussia luciferase, whereas MCMV-3D addition-
ally expresses the ovalbumin (OVA)-derived SIINFEKL peptide
epitope. MCMV downmodulates surface MHC-I expression in
infected cells, possibly leaving CTLs incapable of recognizing
their targets (Gold et al., 2004; Hansen et al., 2010; Krmpotic
et al., 1999). We therefore also used MCMV-3D-DvRAP, which
lacks m06 andm152, two viral regulators of antigen presentation
(vRAP) genes interfering with MHC-I recognition (Ziegler et al.,
1997), to study the effect of MHC-I downregulation on CTL
effector function.
To determine MCMV tropism after subcutaneous (s.c.)
footpad infection of C57BL/6 (B6) mice with MCMV-3D, we
used fluorescence microscopy to detect bright-mCherry-
expressing cells in the draining popliteal lymph node at days 1
and 2 after infection. All MCMV-infected cells lacked expression
of CD45 and CD169 and were located below the subcapsular si-
nus floor on the afferent side of the lymph node, approximately
20–30 mm beneath the capsule (Figures 1A–1E). Some MCMV-
infected cells expressed the fibroblast markers podoplanin
(gp38) and ER-TR7-antigen, but not the cell-adhesion molecule234 Immunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc.MAdCAM (data not shown). Thus, the MCMV strains used in
this study initially infect fibroblast- or pericyte-like stromal cells,
but not macrophages or dendritic cells. The number of mCherry+
virus-infected cells as determined by microscopy strongly
correlated with the MCMV-encoded Gaussia luciferase activity
(Figure 1F and data not shown). Therefore, we used the number
of intact virus-infected cells to determine infected cell densities
throughout this study. Taken together, different microscopy
techniques allowed for a clear and unbiased quantification
of the density of intact virus-infected cells in defined micro-
anatomical regions.
CTLs Fail to Recognize Virus-Infected Cells Protected
by Viral Immune Evasion
We tested the ability of CTLs to directly detect and kill cells
infected by different variants of MCMV after adoptive transfer
of TCR-transgenic, FP-expressing, SIINFEKL-Kb-specific OT-I
cells into B6 recipients. These mice were immunized with
SIINFEKL peptide and poly(I:C) or with OVA protein together
with MVA. Both procedures induced expansion and maturation
of OT-I CTLs within 4–6 days (Figures 2A and 2B). The percent-
age of expanded CD44hi OT-I CTLs present in blood reliably
predicted the number of OT-I CTLs in lymph nodes 2 days later
(Figure 2C), allowing the analysis of MCMV infection in mice
harboring defined numbers of virus-specific CTLs.
One day after MCMV-2D infection, CTLs expectedly did not
express the activation marker CD69, and ex vivo two-photon
microscopy showed that CTLs failed to attach to or kill infected
cells (Figures 2D and 2E; Movie S1). Upon infection with MCMV-
3D, OT-I CTLs strongly upregulated the activation marker CD69
but remained highly motile and established only a few contacts
with infected cells. Consequently, mostMCMV-3D-infected cells
remained intact, even in the presence of high numbers of acti-
vated CTLs (Figures 2D and 2F; Movie S1).
In contrast, in lymph nodes with high CTL densities, most
MCMV-3D-DvRAP-infected cells were killed within 24 hr after
infection (Figure 2G;Movie S1). Together, these findings demon-
strate that viral MHC-I immune evasion protects MCMV-3D-
infected cells from CTL-mediated killing and that in the absence
of viral immune evasion, high CTL densities correlate with local
eradication of infected cells.
Next, we characterized migration parameters of CTLs within
the first 14–20 hr after infection. Compared to CTLs in mock,
MCMV-2D, or MCMV-3D infection, CTLs that attacked MCMV-
3D-DvRAP-infected cells showed significantly reduced track
speeds (Figure 3A). Furthermore, CTLs showed very low motility
coefficients, a measure for CTL displacement over time, accord-
ing to the random-walk-hypothesis framework (Beltman et al.,
2009). Also, CTL turning angles were increased during local
confinement to regions with infected cells (Figures 3B–3D).
These findings demonstrate that CTLs migrate at low velocities
and stay confined in small tissue volumes while recognizing
virus-infected cells and that viral immune evasion significantly
alters CTL migration behavior and killing of virus-infected cells.
Two-Photon Microscopy Reveals that Multiple CTLs Are
Needed to Robustly Kill Virus-Infected Cells
MCMV-3D-DvRAP-infected targets usually remained intact after
contact by a single OT-I CTL (Figures S1A and S1B;Movie S1). In
Figure 1. Single-Cell Visualization Allows for Quantification of Virus-Infected Cell Numbers
(A) Detection of mCherry+ MCMV-infected cells (white) by epi-fluorescence microscopy in cortical region of the popliteal lymph node 48 hr after MCMV-3D
footpad injection (106 plaque-forming units [PFU]) into B6 mice.
(B) One day after infection, MCMV-infected cells expressing mCherry (red) and second harmonic generation signals (SHG, blue) were observed by two-photon
microscopy. Scale bar represents 20 mm.
(C) Non-infected lymph node imaged at an identical region. Scale bar represents 20 mm.
(D) MCMV-3D-infected cells (red) and counterstaining with anti-CD45 (upper panel; green) and anti-CD169 (lower panel; cyan). Pictures shown in (A)–(D) are
representative of >15 experiments. Scale bar represents 20 mm.
(E) Distance of MCMV-infected cells to the lymph node capsule. Dots represent cells, and bars represent medians. Data were pooled from six mice from two
independent experiments. ns, not significant.
(F) After infection with different doses of MCMV-3D, the number of MCMV-infected cells observed by microscopy was plotted against MCMV-expressed
luciferase signals. The red line represents linear regression, and the 99% prediction interval is shown in gray.contrast, when numerous CTLs interacted simultaneously
or serially with MCMV-3D-DvRAP-infected cells, we frequently
observed target cell disruption (Figure 4A; Movie S2). The killing
process of the virus-infected cells took some time, and morpho-
logical changes were observed over 10–40 min, long before
the target cells finally disappeared. Typically, we observed
initial morphological disturbances followed by the formation of
blebs and later by the shedding of larger portions, resembling
apoptotic bodies, of the mCherry-labeled cell body (Figure 4A
[lower panel], Figure 4B).
The cognate interaction between CTLs and their targets rarely
led to stable synapses with complete arrest of CTLs. Instead,
while contacting their targets, CTLs remained motile with an
instantaneous velocity of 2–4 mm/min for periods of approxi-
mately 10–15 min (Figure 4C) before regaining velocity. This
type of interaction between targets and CTLs resembled the for-
mation of migratory ‘‘kinapses’’ observed between T cells and
dendritic cells presenting antigenwith intermediate or low affinity
during T cell priming (Dustin, 2008). Throughout the manuscript,
we will use the term ‘‘kinapse’’ to describe this type of migratoryinteraction between CTLs and virus-infected cells during target-
cell killing.
Direct observation of CTL-target-cell interaction behavior and
quantification of target-cell fate revealed that killed virus-in-
fected cells experienced a median of 3.5 distinct CTL contacts,
whereas surviving cells were rarely targeted (0 median contacts;
Figure 4D). Killed targets encountered a cumulative median con-
tact time of 50min (Figure 4E). Individual contacts between CTLs
and surviving targets lasted 8.5 min (Figure 4F), and individual
contacts between CTLs and killed targets lasted for approxi-
mately 9.0 min (median; Figure 4F). These observations indicate
that successful killing of infected cells is not simply determined
by the duration of individual CTL contacts.
When comparing thedifferentMCMVstrains,weobserved that
1% and 8% of CTLs established contacts with MCMV-2D- and
MCMV-3D-infected cells, respectively, whereas 38% of the
CTLs contacted MCMV-3D-DvRAP infected cells (Figures 4G
and 4H). Furthermore, we found that virus-infected cells were
usually disrupted within 20–60 min (but rarely within 10 min)
after the first observed CTL contact (Figure 4I). Together, theseImmunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc. 235
Figure 2. Cytotoxic T lymphocytes Fail to
Kill Infected Cells Protected by Viral MHC-I
Immune Evasion
Protocol for generation of CTLs: 105 naive
FP-expressing OT-I cells were transferred into
C57BL/6 mice and activated at day 1 by different
protocols. After expansion, different MCMV
strains were injected into the footpad, and
two-photon microscopy was used for studying
CTL behavior and the number of infected cells in
the draining popliteal lymph node.
(A) On day 5 after priming, all GFP+ FP-OT-I CTLs
expressed CD44 after expansion. Flow cytometry
was gated on all blood CD8+ T cells.
(B) The percentage of FP-OT-I CTLs (of total
leukocytes) in blood after priming by different
protocols (data were pooled from at least six
independent experiments).
(C) The percentage of OT-I CTLs in blood is plotted
against the percentage of OT-I CTLs found in
brachial lymph nodes. Dots represent lymph
nodes, and the red line represents linear regres-
sion. Data were pooled from three independent
experiments.
(D) One day after infection, OT-I CTLs in the
popliteal lymph node were stained for surface
CD69 expression. MCMV-2D (2D) was used as a
SIINFEKL-negative control, and Kruskal-Wallis
and Dunn’s tests were used for comparing multi-
ple groups. Dots represent lymph nodes, and
red lines represent medians. Data were pooled
from at least three experiments. **p < 0.01; ns, not
significant.
(E–G) One day after infection with the viruses
indicated, OT-I CTLs were observed in regions
harboring infected cells (upper panel), and
numbers of infected cells were counted (lower
panel). In the upper panels, 10 min tracks are
shown in gray, and scale bars represent 20 mm. In
the lower panels, dots represent lymph nodes, and
lines represent linear regression (E and F) or one-
phase exponential decay (G). Data were pooled
from at least six experiments.
CTL priming was performed with SIINFEKL and
poly(I:C) in (C)–(G).findings indicate that induction and execution of pro-apoptotic
signaling cascades in virus-infected cells does not ensue instan-
taneously after a single CTL contact but that the accumulation of
multiple CTL contacts determines the fate of virus-infected cells.
Different Virus-Infection Models Reveal Low Average
CTL PCKRs
To study CTL-mediated killing in another infection model, we
generated two reporter strains of the poxvirus MVA (Kremer
et al., 2012). Injection of MVA-mCherry into the footpad led
to infection of CD169+ subcapsular sinus macrophages in
the draining lymph node (data not shown). OT-I CTLs killed
MVA-OVA-mCherry- but not MVA-mCherry-infected cells (Fig-
ure 5A; Movie S3). As observed during MCMV-3D-DvRAP
infection, CTLs within the MVA-OVA-mCherry-infected lymph
nodes showed reduced track speed (Figure 5B), antigen-
triggered dynamic contacts (Figure 5C), and disruption of
targets that depended on CTL density at the site of infection
(Figure 5D).236 Immunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc.To quantify CTL-mediated killing of the different virus-infected
cells, we analyzed the expression kinetics of the mCherry re-
porter to test whether detection of all infected cells can be
expected during the two-photon imaging time windows.
In vitro infection revealed stronger and faster mCherry expres-
sion byMVA at 4–8 hr after infection (Figures S2A–S2D), whereas
after 12 hr, both MVA and MCMV were robustly detectable both
in vitro and in the infected lymph node (Figures S3A–S3D; Movie
S4). Furthermore, virus-specific CTLs could already recognize
their specific virus-encoded peptide at 8 hr after infection
(Figures S3D and S3E). Thus, direct observation of single CTLs
and single virus-infected cells was feasible from 12–24 hr after
infection.
Next, we used two-photon-microscopy-derived datasets from
the different virus-infection models to calculate PCKRs of OT-I
CTLs, i.e., the theoretical average number of infected cells killed
per CTL per day (Elemans et al., 2012). PCKR values reported in
the literature are highly variable and were calculated on the basis
of indirect assays or on assays relying on adoptively transferred
Figure 3. Cognate Antigen Presentation
and Viral Immune Evasion Determine the
Migration Behavior of CTLs while Attacking
Virus-Infected Cells
(A–C) One day after infection, two-photon micro-
scopy was used to quantify OT-I CTL track speed
(A), motility coefficient, (B) and turning angles (C) in
movies with intact MCMV-infected cells. Dots
represent median values from all tracks per movie,
and red bars represent IQRs. Kruskal-Wallis and
Dunn’s tests were used for comparing multiple
groups. Data were pooled from two to six inde-
pendent experiments per condition. *p < 0.05;
**p < 0.01; ns, not significant.
(D) OT-I CTL population median track straightness
(y axis) was compared to median track speed
(x axis) per imaging region (dots represent median
track straightness and median track speed for the
different viruses per mouse).
CTL priming was performed with SIINFEKL and
poly(I:C); see also Figure S1.artificial targets (Elemans et al., 2012; Regoes et al., 2007). On
the basis of our direct observation of endogenous virus-infected
cells killed, here we calculated PCKRs of 4.8 (median, MCMV-
3D-DvRAP) and 4.2 (median, MVA-OVA-mCherry; Figure 5E).
Notably, viral MHC-I immune evasion of MCMV-3D reduced the
PCKR to 0.0 (median), thus resembling infection with MCMV-
2D (Figure 5E). Together, direct visualization and quantification
revealed that the OT-I CTL population showed a limited killing ef-
ficiency in different infectionmodels and that viralMHC-I immune
evasion dramatically reduced CTL killing efficiency in vivo.
Intralymphatic CTL Transfer and Mathematical
Modeling Confirm Low Killing Rates
To determine whether CTLs generated from the endogenous
pool of CD8+ T cells show killing efficiencies similar to those of
TCR-transgenic CD8+ T cells, we generated CTLs in wild-type
or perforin-deficient B6 mice (Prf/) by intraperitoneal infection
with MCMV-3D. After 6–8 days, MCMV-specific CTLs were
isolated by tetramer staining (Altman et al., 1996). Employing
our previously developed technique of intralymphatic injection
(Braun et al., 2011), we delivered tetramer-enriched (60%
purity) or tetrameter-sorted (90% purity) CTLs or negatively
enriched CTLs (depletion of CD62Lhi and non-CD8+ T cells)
into the afferent lymphatic vessel draining toward the popliteal
lymph node of MCMV-3D-DvRAP-infected mice. One day after
intralymphatic transfer, we found that the reduction of virus-in-
fected cell numbers, i.e., killing of targets, was dependent on
the local number of B6 CTLs (Figures 6A and 6B). Similar to B6
CTLs, tetramer-sorted Prf/ CTLs showed the typical migration
behavior during target cell attack but were unable to disrupt
virus-infected cells (Figure 6C; Movie S4).
To quantify CTL killing efficiencies after intralymphatic injec-
tion, we used a mathematical model to describe the killing of
virus-infected cells at different CTL densities 0–24 hr after infec-
tion (Supplemental Experimental Procedures; Figure 6D). This
model makes no assumptions on CTL killing mechanisms and
has been developed in accordance with published modeling
approaches (reviewed in Elemans et al., 2012, and Regoeset al., 2007). Furthermore, this model calculates average PCKR
values for the entire CTL population, and the results obtained
can be directly compared to the counting approach described
in Figure 5. Applying this simple mathematical model, we calcu-
lated PCKRs from 2.0 to 10.4 for tetramer-enriched, tetramer-
sorted, or negatively selected polyclonal CTLs (Figure 6E). In
contrast, Prf/ CTLs showed a PCKR close to 0 (Figure 6E).
Thus, PCKRs obtained by intralymphatic transfer of in-vivo-
primed CTLs and mathematical modeling were in agreement
with the PCKRs obtained by real-time two-photon imaging,
together arguing for a limited average PCKR for CTLs attacking
virus-infected cells.
Low In Vivo CTL-Mediated Killing Rates in the Dermis
BecauseCTLkillingefficiencymightbedifferent inanon-lymphoid
organ, we next studied CTL killing in the dermis of T-cell-deficient
mice (Cd3e/; Rag2/). These animals were reconstituted with
FP-OT-I or FP-CD8+ T cells. Intraperitoneal virus infection was
then used to prime and expand T cells (Figure S4A). In vivo two-
photon microscopy showed that 1 day after secondary s.c. ear
infection with MCMV-3D-DvRAP, but not after infection with
MCMV-3D, OT-I CTLs migrating around infected dermal fibro-
blastswere found toexhibit the typical dynamicscanningbehavior
characterized by low track speed and low motility coefficients
(Figures S4B–S4D). Likewise, mice reconstituted with polyclonal
CD8+ T cells and primed intraperitoneally with MCMV-3D dis-
played CTLs characteristically scanning infected cells in the
dermis, aswell as local eradication ofMCMV-3D-DvRAP-infected
targets (Figures S4E–S4G; Movie S5). In the skin, we observed
median PCKRs of 16.0 and 12.5 for OT-I and polyclonal CTLs,
respectively (Figure S4H). Thus, two-photon in vivo imaging of
the infected skin supports the conclusion that CTLs show limited
killing efficiency when attacking virus-infected stromal cells.
Calcium Signaling in Virus-Infected Cells Reveals
Heterogeneity of Single CTL-Contact Events
It is currently unclear whether all CTLs specific to the same
epitope show the same killing rate or whether some CTLs killImmunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc. 237
Figure 4. Two-Photon Microscopy Allows for Real-Time Visualization of CTL-Mediated Killing of Virus-Infected Cells
(A) Upper panel: two-photon microscopy revealed disruption of mCherry+ infected cells (red) and contact events by OT-I CTLs (green) 14 hr after MCMV-3D-
DvRAP infection of mice harboring FP-CTLs (elapsed time displayed). Scale bar represents 20 mm. Lower panel: example of mCherry+ cell-body morphology
during disruption (CTLs not shown). Dots represent center spots of original cell and large fragments. Scale bar represents 5 mm.
(B) Example of four CTLs (red, orange, green, and blue tracks) that interacted with one virus-infected target (red).
(C) Instantaneous speed of the four CTLs shown in (B).
(D) Number of OT-I CTL contacts (>1min) with MCMV-3D-DvRAP-infected target cells that survived (intact) or were killed during the observation period of 1–3 hr.
Dots represent target cells. ***p < 0.001.
(E) Cumulative CTL-contact duration per target cell. Dots represent target cells. ***p < 0.001.
(F) Duration of individual CTL-contact events. Dots represent CTL contacts. ns, not significant.
(D–F) Red bars represent the median with IQR, and data were pooled from nine movies from four independent experiments. A Mann-Whitney test was used for
comparing intact and killed target cells.
(legend continued on next page)
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Figure 5. CTLs Show Low Average PCKRs in Both Poxvirus and Cytomegalovirus Infection Models
Experimental setup for two-photon imaging of MVA-infected lymph nodes: transfer of FP-OT-I (day 0), expansion with SIINFEKL plus poly(I:C) (day 1), infection
with MVA or MVA-OVA (day 6), and two-photon imaging (day 7).
(A) One day after footpad infection with MVA or MVA-OVA (107 PFU), two-photon microscopy was used for observing OT-I CTLs (green) at the site of MVA-
infected mCherry+ cells (red).
(B) Median track speed of the OT-I CTL population in non-infected or MVA- or MVA-OVA-infected lymph nodes. Dots represent the mean of >50 CTLs analyzed
per lymph node, and red bars represent the mean ± SD. A t test with Welch’s correction was used for comparing MVA and MVA-OVA. **p < 0.01.
(C) OT-I CTL contacts with MVA- or MVA-OVA-infected cells were analyzed. Dots represent contact duration per CTL, and red bars represent IQRs. A Mann-
Whitney test was used for comparing MVA and MVA-OVA. **p < 0.01.
(D) One day after infection, the number of OT-I CTLs and MVA-infected cells per imaging region was correlated (green dots, MVA infection; green line, linear
regression; red dots, MVA-OVA infection; red line, one-phase exponential decay). Dots represent individual mice (B), cells (C), and lymph nodes (D). Data were
pooled from three independent experiments in (B)–(D). Scale bars represent 20 mm.
(E) OT-I CTLs PCKRs were calculated from automated-cell-tracking data for different MCMV and MVA strains. Dots represent movies, and red bars represent
IQRs. A Kruskal-Wallis test was used for comparing multiple groups (outliers are not shown but were included in the test). *p < 0.05; ns, not significant.more efficiently than others. Thus, we first tested whether all
CTLs that are in contact with infected cells show signs of activa-
tion. Using OT-I CTLs expressing retrovirally transduced nuclear
factor of activated T cells (NFAT)-GFP (Aramburu et al., 1998)
and H2B-mOrange reporter constructs, and assuming that
cognate recognition results in nuclear NFAT translocation within
1–3 min (Marangoni et al., 2013), we addressed whether CTLs in
contact with infected cells can readily recognize the target. After
MCMV-2D or -3D infection, the NFAT-GFP fluorescent signals
remained in the CTL cytoplasm, which is in agreement with the
absence of killing of these virus variants. In contrast, after
MCMV-3D-DvRAP infection, 80% of CTLs in contact with in-
fected cells—but also some CTLs not in contact with targets—
showed nuclear NFAT-GFP (Figures S5A–S5D; Movie S6; data
not shown). Thus, CTLs were usually activated during target-
cell contact. However, because CTLs frequently retained the
NFAT signal in the nucleus after target disengagement (Maran-(G) Duration of OT-I CTL contact with MCMV-2D-, MCMV-3D-, and MCMV-3D-Dv
shown (independent analysis of dataset used in D–F). *p < 0.05; ns, not significa
(H) Percentage of CTLs that showed target-cell contact (data from G).
(I) Time from first observed CTL contact to death of MCMV-3D-DvRAP-infected c
in (A) and (B) (relative frequencies and binned data from 76 killed infected cells f
CTL priming was performed with SIINFEKL and poly(I:C) in (A)–(H). In (I), data wigoni et al., 2013), NFAT signaling did not allow us to distinguish
between CTLs with different killing rates.
Perforin pores in the plasma membrane have been suggested
to trigger a transient calcium (Ca2+) flux in the target cell (Keefe
et al., 2005). To gain further insights into the functional heteroge-
neity of CTLs, we therefore qualitatively and quantitatively
analyzed CTL-induced Ca2+ influx in infected targets. To study
Ca2+ fluxes in virus-infected cells, we replaced the luciferase-
encoding sequence of MCMV-3D and MCMV-3D-DvRAP with
a sequence encoding the ultra-sensitive Ca2+ sensor GCaMP6s
(Chen et al., 2013), resulting in the reporter viruses MCMV-3D-
Ca and MCMV-3D-DvRAP-Ca, respectively (Figures S6A–
S6C). After footpad infection of non-immunized B6 mice with
MCMV-3D-Ca or MCMV-3D-DvRAP-Ca, most infected cells
showed spontaneous short Ca2+ fluxes that lasted on average
6 s (median; Figures 7A–7D; Movie S7). After infection with
MCMV-3D-DvRAP-Ca, OT-I CTLs dynamically interacted withRAP-infected cells. Here, data from CTLs not in contact with infected cells are
nt.
ells. Target-cell death was defined as complete target disintegration, as shown
rom four independent experiments are shown).
th MVA-OVA priming was also added; see also Figures S2, S3, and S4.
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Figure 6. Intralymphatic CTL Transfer and
Mathematical Modeling Show Low Killing
Rates
Protocol for intralymphatic transfer: MCMV-
3D-DvRAP footpad infection (0 hr), intralymphatic
injection of different types of CTLs (4 hr), and
two-photon imaging of single time points
(24 hr).
(A) One day after infection and intralymphatic
delivery of M45-tetramer-enriched CTLs (red) or
M45-, M38-, and M139-tetramer-sorted CTLs
(blue), the number of MCMV-3D-DvRAP-infected
cells and CTLs per imaging region was counted
from images of single time points.
(B) Same as (A) either without cell transfer
or after injection of negatively enriched CTLs
(magnetic depletion of CD62Lhi and non-CD8+
T cells).
(C) Same as (A) after injection of perforin-deficient
tetramer-sorted CTLs.
(A–C) Data pooled from seven independent
experiments (dots represent lymph nodes, and
lines represent exponential decay). CTL priming
was performed with intraperitoneal infection of
CTL-donor mice with MCMV-3D.
(D) Mathematical modeling calculating the kinetics
of infected cell numbers in a standard imaging
region at the infected site of the lymph node cortical sinus, depending on the number of CTLs present (plot of infected cell numbers over time).
(E) The number of infected cells killed per T cell per day (PCKR) for the different CTL populations was calculated by the mathematical model from the raw data
(median and 95% confidence interval) shown in (A)–(C). See Supplemental Experimental Procedures for details on the mathematical model.and triggered long-lasting Ca2+ fluxes in infected targets (Figures
7E–7G; Movie S7). CTL-induced Ca2+ fluxes lasted for 80 s (me-
dian; interquartile range [IQR] = 40–240 s; Figures 7E–7G) and
started 480 s (median) after CTL encounter (IQR = 60–820 s; Fig-
ure 7H). Although CTLs intensively contacted infected cells, 40%
failed to induce a long-lasting Ca2+ flux (Figure 7I), and only 10%
of CTLs induced three or four death-associated Ca2+ fluxes (Fig-
ure 7J). Perforin-deficient CTLs failed to elicit long-lasting Ca2+
fluxes and cell death (Figure 7K; Figure S6D). Together, these
findings reveal that individual CTLs and CTL contacts targeting
virus-infected cells show strong functional heterogeneity.
Cytotoxic T Lymphocytes Cooperate during Killing of
Virus-Infected Cells
Because single CTL contacts frequently failed to trigger long-
lasting Ca2+ influx or death of target cells, we next addressed
whether CTLs cooperate while killing virus-infected cells. In all
of the above-described imaging models, virus-infected cells
were disrupted more frequently when they were contacted by
several rather than single CTLs. To test for CTL cooperativity,
we choose a null hypothesis that assumed that every CTL con-
tact is an independent event and that previous contacts do not
influence the target cell’s death probability. This Bernoulli-series
null hypothesis states that the probability p(n) that a target
cell will die after n interactions is given by the term p(n) = 1 –
(1 – p(1))n. Data from 660 individual MCMV-3D-DvRAP-infected
target cells were grouped according to the total number of CTL
contacts observed per target cell. Targets without any observed
CTL interactions died with a probability of p(0) = 0.01, whereas
targets with a single or two CTL contacts died with a probability
of p(1) = 0.15 or p(2) = 0.28, respectively. In the case of three or
five CTL contacts, the probability that an infected cell would die240 Immunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc.was significantly higher than predicted from the null hypothesis
of independent interaction outcomes (Figures 7L and 7M).
Thus, CTLs were able to cooperate to kill virus-infected cells
by increasing the probability of target cell death after multiple
CTL encounters.
DISCUSSION
In the present study, we visualized how CTLs killed virus-
infected cells in vivo. We used MCMV and MVA reporter
constructs that, after s.c. injection, infected draining lymph
node stromal cells and subcapsular sinusmacrophages, respec-
tively. Because all reporter viruses encoded mCherry, we could
clearly identify single infected cells and use time-lapse ex vivo
and in vivo two-photon microscopy to determine their fates after
they were contacted by effector CD8+ T cells.
Two-photon imaging revealed that in most situations,
migrating CTLs do not come to a complete arrest to establish
a static synapse with their target. Stable and static synapses
have been described in lymph nodes (1) in vivo between anti-
gen-presenting cells and T cells during defined stages of T cell
priming and (2) in vitro on coated surfaces between CTLs and
targets (Mempel et al., 2004; Ritter et al., 2015). As described
for static synapses, the formation of dynamic kinapses observed
in the present study also relied on the cognate interaction be-
tween TCR and MHC-I-presented antigen, because kinapses
do not form between OT-I CTLs and cells infected with
MCMV-2D (no cognate antigen) or MCMV-3D (low surface
MHC-I expression). Among other factors, the formation of static
immunological synapses has been shown to depend on integrin
activation, which allows firm adhesion and complete arrest
of migrating cells (Liu et al., 2009). Interestingly, treatment of
Figure 7. CTLs Trigger Ca2+ Fluxes in Virus-Infected Cells and Cooperate during Killing
(A) One day after infection with MCMV-expressing Ca2+ sensor GCaMP6s (MCMV-3D-DvRAP-Ca), two-photon microscopy was used to record GCaMP6s
intensity (green) in virus-infected cells (red).
(B) Kinetics of GCaMP6s intensity in an infected cell imaged at 0.2 Hz.
(C) Ca2+ flux (defined as GCaMP6sbright event) duration in virus-infected cells in the absence of specific CTLs (dots represent cells, and red bars represent IQRs;
n = 98 infected cells from three mice).
(D) Kinetics of Ca2+ fluxes in one infected cell imaged for 10 min at 0.07 Hz.
(E) In lymph nodes withMVA-OVA-primed CTLs present, a CFP+ OT-I CTL (blue; dotted line) contacted aMCMV-3D-DvRAP-Ca-infected cell (long flux defined as
GCaMP6sbright event lasting >30 s).
(F) Kinetics of a long-lasting Ca2+ flux of an infected cell imaged for 10 min at 0.05 Hz. The green line represents the locally weighted scatterplot smoothing curve.
(G) Duration of Ca2+ fluxes of infected cells that were not contacted, were contacted but stayed intact, or were contacted and killed. Dots represent cells, and red
bars represent IQRs. A Kruskal-Wallis test was used for comparing multiple groups. Data were pooled from four experiments from six different mice for a total of
307 flux events analyzed. **p < 0.01; ***p < 0.001; ns, not significant.
(H) Time interval between CTL contact and subsequent long-lasting Ca2+ flux (n = 79 events from four experiments analyzed; red bars represent IQRs).
(I) Percentages of CTL contacts that were followed by a long-lasting Ca2+ flux (n = 128 CTLs). Data were pooled from four experiments.
(J) Percentages of different numbers of long-lasting Ca2+ fluxes that followed a CTL contact event (n = 77 CTLs). Data were pooled from four experiments.
(K) Percentage of long-lasting Ca2+ fluxes that followed contacts of Prf/ CTLs (n = 51 contacts pooled from three experiments).
(L) Probability of target-cell death for infected cells contacted by 0–14 CTLs. Hypothetical values for the no-cooperativity null hypothesis (open dots) and
observed data (red squares) are provided. In total, 660 infected cells were analyzed, and data were pooled from >12 independent experiments.
(M)p values for comparingdataderived fromthenull hypothesisandobserveddata (0.05significance level indicatedbydotted line); seealsoFiguresS5, S6, andS7.
Immunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc. 241
mice with neutralizing antibodies against b1- and b2-integrin or
injection of CTLs lacking the TCR adaptor protein ADAP,
involved in TCR signaling leading to integrin activation, did
not show differences in the slow but dynamic CTL migration
behavior during the attack on infected cells or during the faster
migration when CTLs were not contacting infected target cells
(Figure S7). Therefore, integrin-independent formation of
dynamic kinapses might represent a mechanism that not only
allows CTLs to deliver the content of their cytotoxic granules
but also keeps them in a motile state to successfully search for
further targets.
By recruiting effector cells to the site of infection, chemokine
receptors such as CXCR3 and CCR5 have been shown to
contribute to CTL function (Hickman et al., 2015; Kastenmu¨ller
et al., 2013). In the present study, we observed no significant dif-
ference between wild-type and CXCR3- or CCR5-deficient CTLs
regarding killing efficiencies in the intralymphatic transfer model
(data not shown). These findings indicate that the mode of CTL
delivery, the strain of virus investigated, and the cell type infected
might affect the differential requirement for chemokine receptors
for CTL recruitment. In our study, CTL attack on virus-infected
cells resembled the behavior of NK cells attacking tumor cells
(Deguine and Bousso, 2013).
In addition to assessing cell disruption on the basis of
changes in cell morphology, we used the genetic Ca2+ sensor
GCaMP6s expressed in the target cell to better understand
CTL-mediated killing. Earlier in vitro studies have suggested
that perforin pores in the plasmamembrane of target cells cause
a transient Ca2+ influx that is sensed by the cells as a sign to
repair plasma-membrane damage (Keefe et al., 2005; Thiery
et al., 2011). In virus-infected cells, expression of GCaMP6s
proved a sensitive and reliable indicator of Ca2+ fluctuations.
In the absence of natural killer cells and CTLs, virus-infected
cells showed spontaneous short Ca2+ fluxes (data not shown),
whereas CTL-induced fluxes could last for several minutes
and reliably indicated subsequent cell death. Our study revealed
that, on average, 8 min elapsed between CTL contact and Ca2+
influx, whereas subsequent cell disruption occurred in most
situations between 20 and 120 min after the first CTL contact.
In one study, in vivo imaging revealed killing of lymphoid cells
within 10–20 min of CTL contact (Mempel et al., 2006), whereas
other studies failed to observe rapid killing of virus-infected ker-
atinocytes, malaria-infected hepatocytes, or tumor cells (Breart
et al., 2008; Cockburn et al., 2013; Hickman et al., 2013).
Notably, when CTLs attack peptide-pulsed B cells, additional
B cell surface molecules (such as SLAMF7) could strengthen
the CTL attachment and affect CTL behavior during killing.
Together, the specific tropism of the pathogen and the targeted
cell type essentially contribute to the outcome of CTL-mediated
immune reactions.
The control of virus infection is critically determined by the
quality of the CTLs generated (Plotkin, 2013; Varadarajan et al.,
2011). CTLs can be heterogeneous with regard to the expression
of effector molecules as well as the expression of co-stimulatory
or inhibitory surfacemolecules (Jenkins et al., 2008; Newell et al.,
2012). The data shown here also reveal that CTLs are heteroge-
neous with regard to nuclear translocation of the transcription
factor NFAT after cognate antigen recognition. Furthermore,
CTLs are highly diverse with regard to their ability to induce242 Immunity 44, 233–245, February 16, 2016 ª2016 Elsevier Inc.death-associated Ca2+ influx in target cells; for example, in
movies with an average duration of 66 min, 40% of the CTLs
were unable to trigger Ca2+ influx, whereas 10% induced three
or four Ca2+ fluxes. This functional CTL heterogeneity helps to
explain the observed overall low average killing rates.
The local presence of antigen-specific regulatory T cells can
affect CTL killing efficiency (Mempel et al., 2006). The presence
of immune-suppressive cells might also explain why intralym-
phatically delivered tetramer-enriched cells kill slightly less
efficiently than very pure tetramer-sorted CTLs.
Two-photon microscopy allowed us to analyze the fate of
single infected cells with regard to their CTL-contact history.
This approach revealed that CTLs exhibited cooperativity in
killing targets when more than two CTLs contacted the infected
cell. The underlying mechanisms for this observation are unclear
but could be explained by the differential expression levels of
granzymes and perforin (and potentially other molecules) in indi-
vidual CTLs (Jenkins et al., 2008). Two CTL contacts did not
result in detectable signs of cooperativity, maybe because the
effect of twoCTL contacts is too small to be revealed in the assay
setup used. In general, if we assume the existence of CTLswith a
high or low killing capacity, it is plausible that multiple contacts
increase the probability that a fully armed CTL actually disinte-
grates the infected cell. Alternatively or additionally, it seems
possible that the accumulation of sub-lethal pro-death signals
delivered by different single CTLs might lead to faster apoptosis
of the target. Together, our data show that CTL cooperativity
helps to combat viral infections.
The average killing efficacy of individual CTLs crucially affects
the outcome of infectious diseases relying on CTL-mediated
killing as a main control mechanism. There is currently no
consensus on even the order of magnitude of in vivo CTL killing
rates in either experimental models or human diseases (Elemans
et al., 2014; Elemans et al., 2012; Hickman et al., 2013). Esti-
mated killing rates of mouse and human CTLs vary considerably,
and it is unknown how much the different viruses studied, the
vaccination protocols applied to CTL generation, or the killing
assays used affect the killing estimates (Garcia et al., 2015).
Further complicating matters, the definition of killing rates often
relies on different rate constants, not taking into account the
number of CTLs that might be responsible for the killing (Ganu-
sov and De Boer, 2008).
We therefore chose to calculate the average number of virus-
infected cells killed per CTL per 24 hr as a simple measure of
the CTL-mediated killing to allow direct comparison between
different models. We determined killing rates either by directly
observing disintegration of infected cells over time by a defined
CTL population size or by determining the ratio of CTLs and
infected cells at given time points after infection. The PCKRs
calculated by these approaches give an average value that
describes the killing efficiency of the whole CTL population
(and not of individual CTLs) without assumptions about CTL
cooperation or the percentage of non-active CTLs. Strikingly,
our data show a consistent range of 2–16 infected cells killed
per CTL per day, irrespective of the investigated epitopes
recognized by the CTL, the method of calculation (counting
or mathematical modeling), the type of cell infected (macro-
phages or stromal cells), or the virus used (MVA or MCMV-
3D-DvRAP).
Because two-photon imaging cannot detect killing events that
might occur before imaging is started, the PCKR values from
direct imaging-based counting might slightly underestimate
killing efficiencies. However, killing of ‘‘non-visible’’ cells does
not affect our mathematical model, because the time point of
killing is not important in this experimental setup. Both direct
counting and mathematical modeling might have limitations,
but all PCKR estimates obtained here (from different viruses in-
fecting different cells, different organs, and by different methods)
are consistent in that they range from 2 to 16 target cells killed
per CTL per day.
It remains unknown for how long a single CTL can maintain a
certain killing rate, and it will be interesting to measure whether
single CTL killing rates increase or decrease after sequential
target-cell encounter.
All together, our data indicate that the average in vivo CTL
killing capacity is rather limited and not in agreement with the
assumption that all CTLs act as ‘‘rapid’’ and ‘‘serial’’ killers that
destroy hundreds or thousands of targets per day (Elemans
et al., 2012). Therefore, protective CTL immunity might require
substantially higher CTL densities than previously thought. This
can possibly explain the failure of some CTL-based vaccines
(Plotkin, 2013; Yewdell, 2010) or the development of chronic viral
infections (West et al., 2011), in which functional CTLs are initially
present but fail to eradicate all virus-infected cells.
EXPERIMENTAL PROCEDURES
MCMV Strains
All MCMV strains were derived from the pSM3fr Smith strain (cloned as a
bacterial artificial chromosome) and were produced and titrated in vitro ac-
cording to standard techniques (Marquardt et al., 2011). GCaMP6s-express-
ing MCMV strains were designed with plasmid pGP-CMV-GCaMP6s (Chen
et al., 2013) obtained from Addgene (plasmid 40753). See Supplemental
Experimental Procedures for details.
MVA Strains
MVA-mCherry and MVA-OVA-mCherry were generated by homologous
recombination using the plasmid vectors pIIIdHR-P7.5 and pLW-73 according
to standard procedures. See Supplemental Experimental Procedures for
details.
Mice
C57BL/6 (B6) mice were bred at the central animal facility at Hannover Medical
School under specific-pathogen-free conditions or purchased from Charles
River or the Jackson Laboratory (JAX). Female or male mice were used at
the age of 6–18 weeks. The following mutant B6 mouse strains were used:
C57BL/6-Tg(CAG-EGFP) (JAX 003291) mice expressing GFP under an artifi-
cial CMV-actin-globin promoter (here named GFP), C57BL/6-Tg(CAG-eCFP)
mice expressing CFP under the beta-actin promoter (JAX 004218), TCR-trans-
genic OT-I CD45.1+mice (derived fromC57BL/6-Tg(TcraTcrb)1100Mjb/J; JAX
003831), F1-cross between GFP and OT-I CD45.1+ (named FP-OT-I), Adap/
mice (C57BL/6J Fyb 3 B6.PL-Thy1a/CyJ 3 B6-Tg(TcraTcrb)1100Mjb),
Cd3e/ mice (C57BL/6-CD3etm1Mal/Orl), Prf1/ mice (JAX 002407), and
Rag2/ mice (JAX 008449). All experiments were conducted in accordance
with the local animal welfare regulations reviewed by the institutional review
board and the Lower Saxony State Office for consumer protection and food
safety (LAVES).
Generation of OT-I CTLs In Vivo
CD8+ T cells from OT-I mice, containing 105 CD8+ TCR Va5+ OT-I cells, were
transferred into recipient mice. OT-I CTL priming was performed by different
regimes. See Supplemental Experimental Procedures for details.Intralymphatic Injection of CTLs
Two to six hours after MCMV-3D-DvRAP infection, 2.5 3 104 to 1 3 105
CTLs diluted in 5 ml PBS were injected in 90 s into the afferent lymph vessel
draining toward the popliteal lymph node, as described before (Braun et al.,
2011).Two-Photon Microscopy
Ex vivo two-photon imaging was performed with custom-build chambers
for imaging explanted lymph nodes, as described in Halle et al. (2009). In
Figure S4, the skin at the site of infection in the ear of anesthetized mice
was imaged directly in vivo. See Supplemental Experimental Procedures for
details.Calculation of Average CTL Killing Rates
We calculated the number of infected cells killed per T cell per day on the basis
of the observed time course of the number of killed virus-infected cells and the
average number of CTLs in two-photon microscopy movies. Data from inde-
pendent experiments were pooled, and average killing rates were reported.
Alternatively, we used the single-time-point imaging data from the intralym-
phatic injection together with the mathematical model to calculate average
CTL killing rates and 95% confidence intervals. See Supplemental Experi-
mental Procedures for details.Statistical Analysis
Statistical analysis was performed with GraphPad Prism 4. When comparing
two groups, we calculated p values with the nonparametric Mann-Whitney
test. To compare multiple groups, we used the Kruskal-Wallis test with Dunn’s
test. All data were pooled from multiple independent experiments. See Sup-
plemental Experimental Procedures for details.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2016.01.010.AUTHOR CONTRIBUTIONS
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